Bortezomib

Bortezomib is a medication used for certain types of cancer. It works by targeting proteins in cancer cells, helping to slow their growth. This drug is administered intravenously or subcutaneously.

Bortezomib is primarily used in the treatment of multiple myeloma and mantle cell lymphoma. It is a proteasome inhibitor, which means it interferes with the growth of cancer cells. Patients often wonder, 'What is Bortezomib used for?' It is typically prescribed when other treatments have not been effective.

Common effects of Bortezomib may include fatigue, nausea, and diarrhea. Some patients also experience peripheral neuropathy, which can cause tingling or numbness in the hands and feet. These effects can vary from person to person.

Bortezomib should be handled with care and administered under medical supervision. It is important to follow the prescribed dosage and administration instructions. Patients with a history of heart or nerve problems should discuss this with their healthcare provider before starting treatment.

Bortezomib can interact with other medications, including those that affect the liver or blood clotting. It is important to inform your healthcare provider about all medications you are taking. Alcohol and certain supplements may also interact with Bortezomib.